<DOC>
	<DOCNO>NCT00079586</DOCNO>
	<brief_summary>The purpose study demonstrate patient undergo coronary artery bypass grafting ( CABG ) CABG-Valve , Isolated Cardiac Valve surgery CPB ( cardiac surgery ) , Angiomax safe effective alternative anticoagulant heparin protamine reversal .</brief_summary>
	<brief_title>Comparing Angiomax Heparin With Protamine Patients Undergoing Cardiopulmonary Bypass ( CPB )</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Inclusion Criteria Provide write informed consent initiation study related procedure . Be least 18 year age . Be schedule CABG , CABG single valve surgery , isolate single valve surgery CPB . Patients undergoing repeat ( redo ) CABG also consider eligible study . Exclusion Criteria Confirmed pregnancy time randomization via IVRS ( woman childbearing potential ) ( Urine serum pregnancy test ) Cerebrovascular accident within 6 month , cerebrovascular accident residual neurological deficit . Intracranial neoplasm , arteriovenous malformation aneurysm . Dependency renal dialysis creatinine clearance &lt; 30 mL/min . Ongoing treatment warfarin ( oral anticoagulant ) time randomization . Patients previously treat warfarin may enrol warfarin therapy safely discontinue baseline INR &lt; 1.3 time control absence heparin therapy . Known allergy Angiomax hirudinderived drug , know sensitivity component product . Patients receive clopidogrel ( Plavix® ) within previous 5 day randomization Patients receive glycoprotein IIb/IIIa inhibitor within previous 48 hour abciximab ( ReoPro® ) 24 hour eptifibatide ( Integrilin® ) tirofiban ( Aggrastat® ) randomization . Patients receive lepirudin ( Refludan® ) argatroban within previous 24 hour prior randomization . Patients receive LMWH thrombolytic within previous 12 hour unfractionated heparin within 30 minute randomization . Participation clinical research study involve evaluation investigational drug device within 30 day randomization . Refusal undergo blood transfusion become necessary . Any disease condition , , judgment Investigator , would place patient undue risk enrol trial , cause inability comply trial . Planned surgical procedure proximal anastomosis precede distal anastomosis bypass graft . Planned ( &gt; 1 ) double ( great ) valve repairreplacement ( e.g . : AVRMVR ) surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>